Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000560036 | SCV000637400 | likely benign | Familial melanoma | 2022-10-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000570741 | SCV000669178 | uncertain significance | Hereditary cancer-predisposing syndrome | 2024-12-06 | criteria provided, single submitter | clinical testing | The p.R51T variant (also known as c.152G>C), located in coding exon 1 of the CDKN2A (p14ARF) gene, results from a G to C substitution at nucleotide position 152. The arginine at codon 51 is replaced by threonine, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear. |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV002476140 | SCV002774530 | uncertain significance | not provided | 2021-08-04 | criteria provided, single submitter | clinical testing |